References
- Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo controlled study. Am J Psychiatry. 2002;159:1896–1901. doi:10.1176/appi.ajp.159.11.1896.
- Ledbetter M. Atomoxetine use associated with onset of a motor tic. J Child Adolesc Psychopharmacol. 2005;15:331–333. doi:10.1089/cap.2005.15.331.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Association Publishing; 2013.
- Cohen LJ, Stein DJ, Simeon D, et al. Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J Clin Psychiatry. 1995;56:319–326.
- Golubchik P, Sever J, Weizman A, et al. Methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder and comorbid trichotillomania: a preliminary report. Clin Neuropharmacol. 2011;34:108–110. doi:10.1097/WNF.0b013e31821f4da9.
- Argüz Çildir D, Kalyoncu T. Trichotillomania associated with aripiprazole: a case report. J Clin Psychopharmacol. 2018;38:98–99. doi:10.1097/JCP.0000000000000821.
- Bolat N, Yavuz M. Fluoxetine induced trichotillomania in a 7-year- old boy: a case report. Anadolu Psikiyatri Derg. 2016;17(Supplement 3):45–47. doi:10.5455/apd.229825.
- Hamalian G, Citrome L. Stimulant-induced trichotillomania. Subst Abus. 2010;31:68–70. doi:10.1080/08897070903442723.
- Narine C, Sarwar SR, Rais TB. Adderall-induced trichotillomania: a case report. Innov Clin Neurosci. 2013;10:13–14.
- Martin A, Scahill L, Vitulano L, et al. Stimulant use and trichotillomania. J Am Acad Child Adolesc Psychiatry. 1998;37:349–350. doi:10.1097/00004583-199804000-00009.
- Kara T, Akaltun İ. Trichotillomania in attention-deficit/hyperactivity disorder under methylphenidate treatment. J Clin Psychopharmacol. 2017;37:484, doi:10.1097/JCP.0000000000000719.
- Akaltun İ, Kara T. Atomoxetine-Related trichotillomania in a Boy with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2017;27:923, doi:10.1089/cap.2017.0113. Epub 2017 Nov 3.
- Ercan ES, Amado S, Somer O, et al. Development of a test battery for the assessment of attention deficit hyperactivity disorder. Turk J Child Adolesc Ment Health. 2001;8:132–145.
- Keuthen NJ, O’Sullivan RL, Ricciardi JN, et al. The Massachusetts General Hospital (MGH) hairpulling scale: 1. Development and factor analyses. Psychother Psychosom. 1995;64:141–145. doi:10.1159/000289003.
- Kose S, Akin E, Cetin M. Adverse drug reactions and causality: the Turkish version of Naranjo adverse drug reactions probability scale. Psychiatry Clin Psychopharmacol. 2017;27:205–206. doi:10.1080/24750573.2017.1332512.
- Hautmann G, Hercogova J, Lotti T. Trichotillomania. J Am Acad Dermatol. 2002;46:807–821. doi:10.1067/mjd.2002.122749.
- Rothbart R, Stein DJ. Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review. Expert Opin Pharmacother. 2014;15:2709–2719. doi:10.1517/14656566.2014.972936.
- Yektaş Ç, Tufan AE. Increased trichotillomania symptoms in a child with fluoxetine treatment. Clin Neuropharmacol. 2017;40:95–96. doi:10.1097/WNF.0000000000000205.
- Jefferys D, Burrows G. Reversal of trichotillo-mania with aripiprazole. Depress Anxiety. 2008;25:40. doi: 10.1002/da.20395
- Pourcher E, Rémillard S, Cohen H. Compulsive habits in restless legs syndrome patients under dopaminergic treatment. J Neurol Sci. 2010;290:52–56. doi: 10.1016/j.jns.2009.11.010
- King RA, Scahill L, Vitulano LA, et al. Childhood trichotillomania: clinical phenomenology, comorbidity, and family genetics. J Am Acad Child Adolesc Psychiatry. 1995;34:1451–1459. doi:10.1097/00004583-199511000-00011.